Cost-effectiveness of using amyloid positron emission tomography in individuals with mild cognitive impairment

BACKGROUND: Amyloid positron emission tomography (PET) makes it possible to diagnose Alzheimer’s disease (AD) in its prodromal phase including mild cognitive impairment (MCI). This study evaluated the cost-effectiveness of including amyloid-PET for assessing individuals with MCI. METHODS: The target...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Young-Sil, Youn, HyunChul, Jeong, Hyun-Ghang, Lee, Tae-Jin, Han, Ji Won, Park, Joon Hyuk, Kim, Ki Woong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364075/
https://www.ncbi.nlm.nih.gov/pubmed/34391439
http://dx.doi.org/10.1186/s12962-021-00300-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364075/
https://www.ncbi.nlm.nih.gov/pubmed/34391439
http://dx.doi.org/10.1186/s12962-021-00300-9

Ejemplares similares